Description
Dasatinib Tablets 70 mg is a medication used primarily for the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), particularly in patients with Philadelphia chromosome-positive (Ph+) disease. It is a tyrosine kinase inhibitor that works by targeting and inhibiting the BCR-ABL fusion protein, which is responsible for the abnormal growth of cancer cells. By blocking this protein, Dasatinib helps to slow or stop the proliferation of leukemia cells.
The 70 mg dosage is typically taken once daily, as directed by a healthcare provider. Common side effects may include fatigue, headache, nausea, fluid retention, and low blood cell counts, such as anemia, neutropenia, or thrombocytopenia. Regular monitoring, including blood tests and liver function tests, is essential during treatment to manage potential side effects and ensure the medication is working effectively.
Reviews
There are no reviews yet.